DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 04 · Volume 19 · July 1986 DOI: 10.1055/s-002-10188

Editorial

  • 127
  • Schizophrenia and Antipsychotic Drugs Introductory Papers

  • 128
  • 134
  • 145
    Langer, G.; Ackenheil, M.; Dixon, A. K.; Kurtz-May, G.; Möller, H. J.; Müller-Spahn, F.; Pietzcker, A.; Saletu, B.; Schönbeck, G.:

    The Psychopharmacology and Neuroendocrinology of Neuroleptics: The State of the Art from a Clinical Perspective

  • 149
    Christensen, A. V.; Greil, W.; Haag, H.; Havemann, U.; Kehr, W.; Kuschinsky, K.; Porsolt, R. D.; Rüther, E.; Tegeler, J.:

    Animal Models for Assessing Extrapyramidal-Motor Side-Effects of Neuroleptics

  • 156
  • 161
    Pietzcker, A.; Gaebel, W.; Köpcke, W.; Linden, M.; Müller, P.; Müller-Spahn, F.; Schüssler, G.; Tegeler, J.:

    A German Multicenter Study on the Neuroleptic Long-term Therapy of Schizophrenic Patients

  • 167
  • 172
  • 174
  • 176
    Bender, W.; Haag, M.; Haag, H.; Greil, W.; Engel, R.:

    Compliance in Psychiatry: Development of a Patient Questionnaire

  • 178
    Maier, W.; Philipp, M.; Schlegel, S.; Heuser, I.; Buller, R.; Frommberger, U.; Wetzel, H.; Wilhelmi, D.; Wittenborg, A.; Demuth, W.:

    Operational Diagnoses for Schizophrenic and Schizoaffective Disorders

  • 180
    Philipp, M.; Maier, W.; Frommberger, U.; Wilhelmi, D.; Wetzel, H.; Schlegel, S.; Buller, R.; Heuser, I.; Demuth, W.; Wittenborg, A.:

    Operational Diagnoses for Schizophrenic and Schizoaffective Disorders

  • 182
  • 184
  • 186
  • 188
  • 190
  • 192
  • 194
  • 196
    Bohl, J.; Störkel, St.; Schulze, E.; Tschank, G.; Haas, St.; Krausbeck, E.; Gather, W.; Katzman, K.; Brocks, D.:

    Alzheimer's Disease: A Cerebral Amyloidosis
    A Cooperative Study to Correlate Clinical, Biochemical and Pathologic-anatomical Findings

  • 200
  • 202
  • 206
  • 210
  • 212
  • 214
  • 216
  • 218
    Ruhland, M.; Tulp, M.; Muesch, H. R.; Fuchs, A. M.:

    Timelotem - an Antipsychotic Benzodiazepine Derivative

  • 220
  • 222
  • 224
  • 228
    Naber, D.; Albus, M.; Bürke, H.; Müller-Spahn, F.; Münch, U.; Reinertshofer, T.; Wissmann, J.; Ackenheil, M.:

    Neuroleptic Withdrawal in Chronic Schizophrenia.
    CT and Endocrine Variables are not Valid Predictors of Psychopathological Changes

  • 230
    Schreiber, W.; Kissling, W.; Möller, H. J.; Bäuml, J.; Gain, T.; Bottermann, P.:

    TRH-Test and Psychiatric Disorders

  • 232
  • 233
  • 235
    Laakmann, G.; Neuhauser, H.; Hinz, A.; Neulinger, E.; Wittmann, M.:

    Stimulation of Growth Hormone, Prolactin, and Cortisol by GHRH and DMI in Depressed Patients

  • 237
    Laakmann, G.; Hinz, A.; Munz, T.; Schoen, H.-W.; Wittmann, M.; Zygan, K.:

    Interactions of Alpha-2/Beta Receptors and DMI-lnduced GH, PRL and Cortisol Stimulation

  • 239
    Laakmann, G.; Hinz, A.; Neulinger, E.; Strauss, A.; Wittmann, M.:

    DMI-Induced Growth Hormone Stimulation in Healthy Subjects and Depressed Patients

  • 241
  • 245
  • 247
    Kapfhammer, H. P.; Hoff, P.; Golling, H.; Rüther, E.; Schmauss, M.:

    Cimoxatone and Moclobemide, Two New MAO-lnhibitors, in the Treatment of Major Depressive Disorder

  • 249
    Hoff, P.; Golling, H.; Kapfhammer, H. P.; Lund, R.; Pakesch, G.; Rüther, E.; Schmauss, M.:

    Cimoxaton and Moclobemid, Two New MAO-lnhibitors:
    Influence on Sleep Parameters in Patients with Major Depressive Disorder

  • 251
  • 253
  • 255
  • 257
  • 259
    Giedke, H.; Axmann, D.; Gaertner, H. J.; Rein, W.; Rötzer-Zimmer, F. T.:

    Psychophysiological Predictors of Antidepressant Therapy Response?

  • 262
  • 264
  • 266
  • 268
  • 270
  • 272
  • 276
  • 278
  • 280
    Möller, H. J.; Kissling, W.; Tavan, S.; Winter, I.:

    Is Carbamazepine Able to Increase the Antimanic Effect of Haloperidol?

  • 282
    Cabrera, J. F.; Mühlbauer, H. D.; Schley, J.; Stoll, K. D.; Müller-Oerlinghausen, B.:

    Long-term randomized Clinical Trial on Oxcarbazepine vs Lithium in Bipolar and Schizoaffective Disorders: Preliminary Results.

  • 284
  • 286
  • 290
  • 292
    Dirschedl, P.; Grohmann, R.; Schmidt, L. G.:

    Reliability of Adverse Drug Reaction Assessment

  • 294
    Spieß-Kiefer, C.; Grohmann, R.; Rennig, E.; Rüther, E.; Scherer, J.; Schmidt, L. G.:

    Acute Delirious Syndromes due to Psychotropic Drugs

  • 296
    Wolf, B.; Rüther, E.; Brenner, P.-M.; Poser, W.; Schmidt, L. G.:

    Abuse of and Dependence on Stimulants and Anorexigenic Drugs in Psychiatric Inpatients

  • 298
  • 300
    Grohmann, R.; Dirschedl, P.; Rennig, E.; Scherer, J.; Schmidt, L. G.:

    Methodological Problems in Assessment of Adverse Drug Reactions with Drug Combinations

  • 304
  • 306
  • 308
  • 310
  • 312
  • 314
  • 316
    Waldmeier, P. C.; Bischoff, S.; Bittiger, H.; Hauser, K.; Vassout, A.; Delini-Stula, A.; Haeusler, A.; Schenkel, L.; Storni, A.:

    Pharmacological Profiles of Four New Tetracyclic Dopamine Antagonists, Maroxepine, Citatepine, Eresepine, and Cipazoxapine

  • 318
  • 322
  • 323
  • 326
    Berger, M.; Krieg, J. C.; Rummler, R.; Raptis, C.; Morinigo, A.; Dose, M.; Benker, B.:

    The Treatment of Mania with the Cholinomimetic Drug RS 86

  • 328
  • 333
  • 337
  • 339
  • 341
  • 343
  • 345
  • 347
  • Discusion groups

  • 140
    Bischoff, S.; Bürki, H. R.; Emrich, H. M.; Jaeckel, J.; Kornhuber, J.; Ruhland, M.; Schmid, W. J.; Woggon, B.:

    Biochemical and Molecular Mechanisms of Action of Neuroleptics, Alternatives to the Classical Dopamine Hypothesis: Minutes of the Discussion Group

  • Methodological Problems in Planning, Performing and Analysing of Long-Term Studies with psychotropic Drugs

  • 152
  • Methodology of Clinical Trials

  • 170
  • Pharmaco-EEG, Sleep,Neuropsychophysiology

  • 198
    Wiegand, M.; Berger, M.; Zulley, J.; von Zerssen, D.:

    The Effect of Trimipramine on Sleep in Patients with Major Depressive Disorder

  • Antipsychotic Drugs and Extrapyramidal Side-Effects

  • 204
  • Antipsychotic Drugs:Clinical Studies and Psychophysiology

  • 208
  • Immunology and Neuroendocrinology in Psychic Disorders

  • 226
    Moises, H. W.; Beck, J.; Schindler, L.; Kirchner, H.:

    Decreased Interferon Production in Schizophrenic Patients

  • Antidepressant Drugs

  • 243
  • Lithium

  • 274
  • Adverse Drug Reactions(The AMüP Study Group)

  • 288
  • Experimental Pharmacology

  • 302
    Bering, B.; Spira, F.; Schanz, H.; Gattaz, W. F.; Müller, W. E.:

    Do Human Erythrocyte Membranes Contain Muscarinic Cholinergic Receptors?

  • Drug Epidemiology

  • 320
    Koenig, W.; Rüther, E.; Filipiak, B.; Keil, U.:

    Determinants of Psychotropic Drug Intake in a Metropolitan Population

  • Workshop on One Case Experiments in Pharmacopsychiatry - Possibilities and Limitations

  • 331
  • Workshop on New Aspects of the Placebo Problem

  • 335